GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synthorx Inc (NAS:THOR) » Definitions » Book Value per Share

Synthorx (Synthorx) Book Value per Share : $4.77 (As of Sep. 2019)


View and export this data going back to 2018. Start your Free Trial

What is Synthorx Book Value per Share?

Synthorx's book value per share for the quarter that ended in Sep. 2019 was $4.77.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

Synthorx's current price is $67.99. Its book value per share for the quarter that ended in Sep. 2019 was $4.77. Hence, today's PB Ratio of Synthorx is 14.26.


Synthorx Book Value per Share Historical Data

The historical data trend for Synthorx's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthorx Book Value per Share Chart

Synthorx Annual Data
Trend Dec16 Dec17 Dec18
Book Value per Share
-0.78 -1.44 5.87

Synthorx Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Book Value per Share Get a 7-Day Free Trial Premium Member Only 2.01 5.87 5.54 5.15 4.77

Competitive Comparison of Synthorx's Book Value per Share

For the Biotechnology subindustry, Synthorx's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthorx's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synthorx's PB Ratio distribution charts can be found below:

* The bar in red indicates where Synthorx's PB Ratio falls into.



Synthorx Book Value per Share Calculation

Synthorx's Book Value Per Share for the fiscal year that ended in Dec. 2018 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(184.36-0.00)/31.39
=5.87

Synthorx's Book Value Per Share for the quarter that ended in Sep. 2019 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(151.96-0.00)/31.87
=4.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Synthorx  (NAS:THOR) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Synthorx Book Value per Share Related Terms

Thank you for viewing the detailed overview of Synthorx's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthorx (Synthorx) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11099 North Torrey Pines Road, Suite 290, La Jolla, CA, USA, 92037
Executives
Powell Andrew Kenneth William director C/O COLLAGENEX PHARMACEUTICALS, INC., 41 UNIVERSITY DRIVE, NEWTOWN PA 18940
Ra Capital Healthcare Fund Lp 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Ra Capital Management, L.p. 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter Kolchinsky director, 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter A. Thompson director, 10 percent owner C/O ANTHERA PHARMACEUTICALS, INC., 25801 INDUSTRIAL BOULEVARD, SUITE B, HAYWARD CA 94545
Vickie L Capps director 2985 SCOTT STREET, VISTA CA 92083
Rajeev M. Shah 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Jay Lichter director C/O ARATANA THERAPEUTICS, INC., 11400 TOMAHAWK CREEK PARKWAY, SUITE 340, LEAWOOD KS 66211
Laura Shawver director, officer: President and CEO 1255 CRESCENT GREEN DRIVE, SUITE 250, CARY NC 27518
Avalon Ventures X, L.p. 10 percent owner 1134 KLINE STREET, LA JOLLA CA 92037
Orbimed Advisors Llc director, 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Orbimed Capital Gp Vii Llc 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022

Synthorx (Synthorx) Headlines

From GuruFocus

Synthorx to Present at Upcoming Investor Conferences

By Marketwired Marketwired 11-13-2019

Synthorx Appoints Andrew Powell, J.D., to its Board of Directors

By Marketwired Marketwired 12-20-2018

Monday Morning Market Highlights

By Omar Venerio Omar Venerio 06-08-2020

Synthorx to Present at Jefferies 2019 Healthcare Conference

By Marketwired Marketwired 05-30-2019

Synthorx Announces Pricing of Initial Public Offering

By GlobeNewswire GlobeNewswire 12-07-2018

Synthorx Reports Third Quarter Financial Results

By Marketwired Marketwired 11-06-2019